MTOR and neoplasm: One proposed mechanism by which dormancy confers chemotherapeutic resistance is that stromal cells can induce expression of TBK1, which has been shown in PC3 and C4-2B tumor cells to promote chemotherapeutic resistance via inhibition of mTOR [81].